Net Cash Provided by (Used in) Financing Activities of HERON THERAPEUTICS, INC. /DE/ from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
HERON THERAPEUTICS, INC. /DE/ annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • HERON THERAPEUTICS, INC. /DE/ Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $64,000.
  • HERON THERAPEUTICS, INC. /DE/ annual Net Cash Provided by (Used in) Financing Activities for 2025 was $14,427,000, a 1435% increase from 2024.
  • HERON THERAPEUTICS, INC. /DE/ annual Net Cash Provided by (Used in) Financing Activities for 2024 was $940,000, a 98% decline from 2023.
  • HERON THERAPEUTICS, INC. /DE/ annual Net Cash Provided by (Used in) Financing Activities for 2023 was $54,107,000, a 28% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

HERON THERAPEUTICS, INC. /DE/ Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $14,427,000 +$13,487,000 +1435% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $940,000 -$53,167,000 -98% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $54,107,000 -$20,952,000 -28% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $75,059,000 -$80,969,000 -52% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $156,028,000 +$146,923,000 +1614% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
2020 $9,105,000 -$177,320,000 -95% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2022 2021 FY
2019 $186,425,000 -$171,183,000 -48% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $357,608,000 +$63,877,000 +22% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
2017 $293,731,000 +$236,276,000 +411% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
2016 $57,455,000 -$80,536,000 -58% 01 Jan 2016 31 Dec 2016 10-K 22 Feb 2019 2018 FY
2015 $137,991,000 +$75,883,000 +122% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $62,108,000 +$879,000 +1.4% 01 Jan 2014 31 Dec 2014 10-K 23 Feb 2017 2016 FY
2013 $61,229,000 +$7,716,000 +14% 01 Jan 2013 31 Dec 2013 10-K 19 Feb 2016 2015 FY
2012 $53,513,000 +$29,414,000 +122% 01 Jan 2012 31 Dec 2012 10-K 13 Mar 2015 2014 FY
2011 $24,099,000 +$24,022,000 +31197% 01 Jan 2011 31 Dec 2011 10-K 07 Mar 2014 2013 FY
2010 $77,000 01 Jan 2010 31 Dec 2010 10-K 01 Mar 2013 2012 FY

HERON THERAPEUTICS, INC. /DE/ Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $64,000 +$53,000 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $11,000* +$219,000 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $208,000 +$429,000 +67% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $637,000 -$1,520,000 -172% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $883,000 +$376,000 +74% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q1 2020 $507,000 -$6,032,000 -92% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $6,539,000 +$2,542,000 +64% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q1 2018 $3,997,000 -$161,600,000 -98% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $165,597,000 +$163,067,000 +6445% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q1 2016 $2,530,000 -$348,000 -12% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q1 2015 $2,878,000 +$1,920,000 +200% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
Q1 2014 $958,000 +$346,000 +57% 01 Jan 2014 31 Mar 2014 10-Q 08 May 2015 2015 Q1
Q1 2013 $612,000 +$612,000 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014 2014 Q1
Q1 2012 $0 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.